NCT06144515Active, not recruiting
Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
The study Objective is to collect samples of bone marrow aspirates and peripheral blood of patients with MDS for use in non-clinical research to investigate mitochondrial function sequence and effect of mitochondrial augmentation.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 29 Oct 2023
- Start date
- 9 Feb 2023
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Minovia Therapeutics Ltd.
- Diseases
- Myelodysplastic syndromes
- NCT number
- NCT06144515
What you commit to
- Study type: Observational
- Planned participants: 100
- From 9 Feb 2023 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. History of prior allogeneic hematopoietic stem cell transplantation, cell therapy, gene therapy.
Who the study is looking for
- Male or female patients of 18 years old and up.
- Suspected or previously diagnosed with Myelodysplastic Syndrome.
- Patient able to understand and provide voluntary written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shaare Zedek Medical Center Coordinator of this site? Confirm its status | Jerusalem | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.